Inresa Arzneimittel GmbH

Inresa Arzneimittel GmbH is a medium-sized German pharmaceutical company specializing in the development, approval, and distribution of niche generic products and hospital supplies. Founded in 1993, the company has established itself as a key provider of critical care medications, particularly in the fields of anesthesiology, intensive care, and oncology. The company operates as both a manufacturer and a distributor, holding numerous marketing authorizations for generic injectables and infusions. In addition to its own product portfolio, Inresa provides specialized services such as individual pharmaceutical imports under Section 73.3 of the German Medicines Act (AMG), ensuring that pharmacies and hospitals have access to essential medications that may not be readily available in the local market.